Nutritional advice

Marine oil supplements alleviate pain in rheumatoid arthritis patients

Objectives:
Arthritis patients often take fish oil supplements to alleviate symptoms, but limited evidence exists regarding their efficacy. Therefore, this meta-analysis (systematic review) has been conducted.

Do taking marine oil supplements alleviate pain in arthritis patients?

Study design:
This review article included 42 randomized trials; 30 trials reported complete data on pain.

The trials used treatment durations from 2 weeks to 18 months, with doses of EPA from 0.013 to 4.050 g/day and doses of DHA from 0.010 to 2.700 g/day.
Most trials used marine oil from whole fish, but some used cod liver oil, mussel extracts, seal oil and krill oil.

The trials included 2751 patients with a mean age of 53.8 years (range of mean age of 10-68 years) and the mean disease duration was 9.7 years (range 2.3-19.0 years).

Results and conclusions:
The investigators found a favorable effect [SMD = -0.24, 95% CI = -0.42 to -0.07, I2 = 63%] for using marine oil supplements.

The investigators found in 22 trials a significant effect in patients with rheumatoid arthritis [SMD = -0.21, 95% CI = -0.42 to -0.004] for using marine oil supplements.

The investigators also found in 3 trials a significant effect for other or mixed diagnoses [SMD = -0.63, 95% CI = -1.20 to -0.06] for using marine oil supplements, but no significant effect was found in osteoarthritis patients [5 trials: SMD = -0.17, 95% CI = -0.57 to 0.24].

The investigators found a significant, beneficial effect on pain for marine oil with an EPA/DHA ratio >1.5.

The investigators found a significant positive association between SMD and total dose of EPA and DHA [slope β, 0.13 (g/day), 95% CI = 0.04 to 0.22, p = 0.006], indicating less effect at higher dose, but there was no duration-response relationship [p = 0.568].

The investigators concluded using marine oil supplements (with an EPA/DHA ratio >1.5) alleviates pain in rheumatoid arthritis patients.

Original title:
Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials by Senftleber NK, Nielsen SM, […], Christensen R.

Link:
http://www.mdpi.com/2072-6643/9/1/42/htm

Additional information of El Mondo:
Find here more information/studies about EPA&DHA and chronic diseases.

Serum vitamin D ≥75 nmol/L reduces risk of allergic rhinitis in men

Afbeelding

Objectives:
The role of vitamin D status in the etiology of allergic diseases is uncertain. Therefore, this meta-analysis (systematic review) has been conducted.

Study design:
This review article included a total of 21 observational studies.

Results and conclusions:
The investigators found children with serum 25(OH)D ≥75 nmol/L had significantly reduced odds of aeroallergen sensitization, but neither vitamin D intake during pregnancy nor vitamin D supplementation in infancy were associated with risk of allergic rhinitis.

The investigators found compared to those with serum 25(OH)D 50 nmol/L, individuals with serum 25(OH)D ≥75 nmol/L had a significant decreased risk of 29% [OR = 0.71, 95% CI = 0.56-0.89, p = 0.04] for allergic rhinitis.
However, this association was mainly observed in adult men; prevalence of allergic rhinitis (AR) was lower in men with serum 25(OH)D ≥75 nmol/L compared to men with serum 25(OH)D 50 nmol/L, while this association was not observed in women.

The investigators concluded serum 25(OH)D ≥75 nmol/L reduced odds of aeroallergen sensitization in children and risk of allergic rhinitis in men.

Original title:
Vitamin D status, aeroallergen sensitization, and allergic rhinitis: A systematic review and meta-analysis by Aryan Z, Rezaei N and Camargo CA Jr.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/28102718

Additional information of El Mondo:
Find here more information/studies about vitamin D and chronic diseases.